Yesterdays lacklustre performance was due to an over - reaction on Moderna's vaccine. Now that the dust has settled and people have a greater understanding of not only the questionable results but the complexities to get it to market , the realistic opportunity that Mesoblast has in combating Covid - ARDS can be evaluated . Interesting to note that Moderna has a $26 billion valuation and not single product on market .Mesoblast is about to get Ryoncil approved and 3 others (Heart , Back Pain and now Ards) completed or completing trials with read outs in the next few months . Its actually quite staggering what lies ahead for Mesoblast and as E -Cool says its way, way undervalued !
MSB Trading - 2020, page-9831
-
- There are more pages in this discussion • 13,330 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.030(2.29%) |
Mkt cap ! $1.461B | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.28 | $1.677M | 1.289M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 44452 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 23596 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |